CCND1 and neoplasm: Sunitinib treatment (48 h) of 786-O, RCC24, and Caki-2 tumor cells reduced expression of pro-proliferation genes including cyclin D1, but KTZ treatment did not show a significant decrease in expression of cyclin D1.